『Healthcare Perspectives』のカバーアート

Healthcare Perspectives

Healthcare Perspectives

著者: Siemens Healthineers
無料で聴く

このコンテンツについて

Healthcare Perspectives is a podcast by Siemens Healthineers about medical breakthroughs with the power to improve the lives of patients and their families everywhere.


Meet thought leaders from across the globe, as we discuss our shared vision of fighting the world's most threatening diseases through breakthrough medical technology. Hear how technologies like patient twinning, precision therapy and digitization help medical professionals to make the best possible decisions.


6f0570b4ce66aaf30246c7f725e75cf511acc6f2

Hosted on Acast. See acast.com/privacy for more information.

Siemens Healthineers
科学 衛生・健康的な生活 身体的病い・疾患
エピソード
  • AI and sustainability in radiology
    2025/07/23

    Is it possible for artificial intelligence to make healthcare more environmentally sustainable?

    In the field of radiology, AI may prove to be transformative. It has the potential to streamline processes, cut costs, and increase accuracy in imaging, diagnostics, and prevention.


    When we talk about sustainability, we often think of carbon emissions or climate change. But environmental sustainability means something much broader in healthcare: it’s about how we can preserve resources, whether cost, energy, human capital, and reduce waste and pollution, all while improving health outcomes for everyone, everywhere.


    Today, host Vibhas Deshpande, Head of Sustainability Innovation and Research, Americas at Siemens Healthineers, welcomes Dr. Kate Hanneman, cardiac radiologist at the University of Toronto; Dr. Charles Goh, Chief Medical Informatics Officer at Singapore General Hospital; and Tobias Heimann, head of the Department of Artificial Intelligence Germany at Siemens Healthineers, to explore how the rise of artificial intelligence is reshaping the conversation around sustainability in healthcare.

    Together, they’re helping define what “responsible AI” really means—and what steps healthcare leaders can take now to ensure that AI benefits patients, clinicians and health systems and preserves global resources.


    What you’ll learn in this episode:

    • Why eliminating data redundancy and using foundational models are keys to keeping AI development sustainable
    • AI is used to shorten imaging exams while still maintaining a high image quality, which contributes to energy savings
    • AI can help to arrive at correct diagnosis by improving clinical decision making and alignment to best practice to minimize waste in health systems
    • Sustainability is more than a metric of emissions or kilowatts—it’s also about how we invest intellectual and clinical capital, such as freeing clinicians to do what humans can do best: connect, interpret, and care.


    Connect with Vibhas Deshpande

    • LinkedIn


    Connect with Kate Hanneman

    • LinkedIn


    Connect with Charles Goh

    • LinkedIn


    Connect with Tobias Heimann

    • LinkedIn

    Hosted on Acast. See acast.com/privacy for more information.

    続きを読む 一部表示
    18 分
  • Advancing liver care with non-invasive tests (Part 2)
    2025/06/11

    Metabolic dysfunction-associated steatotic liver disease (MASLD), also known as fatty liver disease, is a chronic liver condition that affects nearly 1 in 3 people worldwide. It is closely linked to obesity, type 2 diabetes, and metabolic syndrome. Unchecked, it can progress to a more severe form of disease called Metabolic Dysfunction-Associated Steatohepatitis (MASH).


    Prognosticating the risk of disease progression in MASLD and MASH has traditionally involved liver biopsy, a process that involves removing a tissue sample with a hollow needle and then examining the sample under a microscope to diagnose and stage disease. However, biopsy has many limitations. Additionally, drug development for MASLD and MASH has proceeded slowly in part due to a reliance on liver biopsy to determine drug efficacy.


    Recently, increasing evidence is suggesting that non-invasive options, for example, imaging examinations along with blood tests that assess likelihood of disease progression such as the Enhanced Liver Fibrosis (ELF) Test, may effectively reduce the need for the more invasive alternative. Key experts in MASLD and MASH share their perspectives about how clinical evidence supports a shift in the way patients with MASLD and MASH could be evaluated in clinical practice and in research.


    Host Matt Gee, Director of Collaborations and External Engagement at Siemens Healthineers, is joined by Prof. William Rosenberg, Deputy Director of the Institute for Liver and Digestive Health at University College London as well as Dr. Veronica Miller, Director of the Forum for Collaborative Research at the University of California, Berkeley School of Public Health; Dr. Arun Sanyal, Professor of Medicine, Physiology, and Molecular Pathology in the Division of Gastroenterology at Virginia Commonwealth University; and Dr. Michelle Long, International Medical Vice President of Metabolic Dysfunction-Associated Steatohepatitis at Novo Nordisk and Associate Professor in the Section of Gastroenterology and Hepatology at Boston University.


    What you’ll learn in this episode:

    • Liver biopsy creates several obstacles for patients and has limitations
    • Drug development faces challenges by the reliance on biopsy as a measure of treatment effectiveness
    • Non-invasive tools may be suitable alternatives to liver biopsy both in clinical practice and in drug development


    Connect with Matt Gee

    • LinkedIn


    Connect with Veronica Miller

    • LinkedIn


    Connect with William Rosenberg

    • LinkedIn


    Connect with Michelle Long

    • LinkedIn


    Connect with Arun Sanyal

    • VCU.edu

    Hosted on Acast. See acast.com/privacy for more information.

    続きを読む 一部表示
    28 分
  • Understanding liver health and MASLD (Part 1)
    2025/05/14

    A reversible liver condition is the fastest growing cause of liver transplantation in Western countries: Metabolic dysfunction-associated steatotic liver disease—or MASLD—affects patients worldwide. It’s characterized by excessive fat accumulation in the liver and can progress into more severe forms of liver disease, potentially resulting in fibrosis, cirrhosis and liver failure.


    Risk factors for developing liver disease include obesity, insulin resistance, type 2 diabetes, and metabolic syndrome. Genetics, unhealthy dietary habits, and a sedentary lifestyle can also play significant roles in its development. Diagnosis typically involves imaging examinations along with blood tests that assess liver function and rule out other causes of liver disease.


    Disease management focuses on lifestyle modifications such as diet and exercise, though new medications are now being prescribed to slow and potentially reverse this condition. Regular monitoring of disease progression is also crucial for successful treatment.


    In this episode, experts in the field of liver disease address the progress happening in the recognition, diagnosis and treatment of the disease.


    Host Matt Gee, Director of Collaborations and External Engagement at Siemens Healthineers, is joined by Dr. Michelle Long, International Medical Vice President of Metabolic Dysfunction-Associated Steatohepatitis at Novo Nordisk and Director of Clinical Research for the Section of Gastroenterology and Hepatology at Boston University; Dr. Arun Sanyal, Professor of Medicine, Physiology, and Molecular Pathology in the Division of Gastroenterology at Virginia Commonwealth University; and Michael Betel, President and Founder of the Fatty Liver Alliance.


    What you’ll learn in this episode:

    • One of the biggest obstacles to diagnosing MASLD before it progresses stems from the lack of visibility and awareness of the disease
    • MASLD is a reversible disease when caught in time
    • MASLD is more complex than a patient’s diet or lifestyle—metabolic dysfunction plays a role
    • Non-invasive testing has become an important tool in advancing patient care


    Connect with Matt Gee

    • LinkedIn


    Connect with Michelle Long

    • LinkedIn


    Connect with Arun Sanyal

    • VCU.edu


    Connect with Michael Betel

    • LinkedIn

    Hosted on Acast. See acast.com/privacy for more information.

    続きを読む 一部表示
    26 分
まだレビューはありません